Design and selection of vaccine adjuvants: Animal models and human trials

Vaccine

Volumn 20, Issue SUPPL. 3, 2002, Pages S56-S64

  Alving, Carl R ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

Author keywords

Animal model; Freund's adjuvant; Herpes simplex virus type 2 vaccine; HIV vaccine; Human trial; Lipid A; Liposomes; Malaria vaccine; MF59; Oil in water emulsions; Prostate cancer vaccine; Vaccine adjuvant

Indexed keywords

ALUMINUM HYDROXIDE; ALUMINUM SALT; ARACHIS OIL; BACTERIAL TOXIN; CANCER VACCINE; CYTOKINE; DRUG CARRIER; DRUG VEHICLE; FATTY ACID; FREUND ADJUVANT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; IMMUNOLOGICAL ADJUVANT; INTRALIPID; LIPOSOME; MALARIA VACCINE; MICROSPHERE; MURAMYL DIPEPTIDE; MURAMYL TRIPEPTIDE; N ACETYLMURAMYLALANYL DEXTRO ISOGLUTAMINYLALANYL DIPALMITOYLPHOSPHATIDYLETHANOLAMINE; NONIONIC SURFACTANT; PHOSPHORYL LIPID A; POLYMER; PROSTATE SPECIFIC ANTIGEN; RECOMBINANT ANTIGEN; SAPONIN; SQUALENE; VACCINE;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DISEASE MODEL; DRUG CHOICE; DRUG EFFICACY; DRUG FORMULATION; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALARIA; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; STANDARDIZATION; ANIMAL; ANIMAL MODEL; CHEMISTRY; EMULSION; IMMUNOLOGY; PHASE 1 CLINICAL TRIAL; REVIEW;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CHEMISTRY, PHARMACEUTICAL; CLINICAL TRIALS, PHASE I; EMULSIONS; HUMANS; LIPOSOMES; MODELS, ANIMAL; VACCINES;

EID: 18744364924     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0264-410x(02)00174-3     Document Type: Article

References (69)

1. AIDS Res. Hum. Retroviruses
2. Vaccine design
3. A compendium of vaccine adjuvants and excipients
4. WHO Tech. Rep. Ser.
5. Rev. Infect. Dis.
6. Weir's handbook of experimental immunology, 5th ed.
7. Adjuvants for a new generation of vaccines. In new generation vaccines
8. Vaccine
9. Curr. Opin. Immunol.
10. Prog. Med. Virol.
11. Vaccine
12. Parasitol. Today
13. Vaccine
14. Vaccine adjuvants: preparation methods and research protocols
15. The theory and practical application of adjuvants
16. Immunobiology
17. Immunol. Today
18. J. Immunol. Methods
19. Biochim. Biophys. Acta
20. Can. J. Public Health
21. Vaccine design
22. Vaccine
23. Biotherapy
24. Intern. Rev. Immunol.
25. CRC Crit. Rev. Microbiol.
26. Bacterial vaccines
27. J. Exp. Med.
28. Immunology
29. Ann. Allergy
30. Bull. WHO
31. J. Am. Med. Assoc.
32. J. Allergy
33. Proc. Soc. Exp. Biol. Med.
34. Ann. Allergy
35. Am. J. Med. Sci.
36. Am. J. Epidemiol.
37. Vaccine Res.
38. Clin. Exp. Immunol.
39. Vaccine
40. Clin. Infect. Dis.
41. Microb. Infect.
42. J. Infect. Dis.
43. Infect. Immun.
44. J. Infect. Dis.
45. J. Infect. Dis.
46. J. Immunol.
47. Vaccines 92. Modern approaches to new vaccines including prevention of AIDS
48. J. Infect. Dis.
49. Vaccine
50. J. Am. Med. Assoc.
51. AIDS Res. Hum. Retroviruses
52. Int. J. Immunopharmacol.
53. Process for making liposome preparation. US Patent no. 6,007,838 [issued 28 December 1999]
54. A Vaccine for induction of immunity to malaria. US Patent no. 6,093,406 [issued 25 July 2000]
55. Proc. Natl. Acad. Sci. U.S.A.
56. Vaccine
57. Blood
58. Infect. Immun.
59. J. Immunol.
60. Vaccine
61. Infect. Immun.
62. Encapsulated high-concentration lipid A compositions as immunogenic agents to produce human antibodies to prevent or treat gram-negative bacterial infections. US Patent no. 5,888,519 [issued 30 Mar 1999]
63. J. Immunol. Methods
64. Semin. Cancer Biol.
65. Semin Oncol.
66. Adv. Drug Deliv. Rev.
67. AIDS Res. Hum. Retroviruses
68. New Engl. J. Med.
69. J. Pharmaceut. Sci.